We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock

Delisted

NMRD was delisted on the 4th of January, 2024.

1 hedge funds and large institutions have $1K invested in Nemaura Medical, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 31 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

98% less capital invested

Capital invested by funds: $46K → $1K (-$45K)

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
1
Deutsche Bank
Germany
$1K +$1.84K +300 New
Citadel Advisors
2
Citadel Advisors
Florida
-$36K -4,995 Closed
SC
3
Scotia Capital
Ontario, Canada
-$9K -1,250 Closed
UBS Group
4
UBS Group
Switzerland
-$1K -78 Closed

NMRD Hedge Fund Activity: Q4 2019 in Review

1 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q4 2019, worth a combined $1K — down 98% from $46K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NMRD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $1.84K. The largest seller was Citadel Advisors, exiting entirely with an estimated $36K sold.

  • 1 institutional investor held Nemaura Medical, Inc. Common Stock (NMRD) as of Q4 2019, down from 3 in Q3 2019.
  • Funds reported $1K of Nemaura Medical, Inc. Common Stock stock for Q4 2019, down 98% quarter-over-quarter.
  • 1 fund opened new Nemaura Medical, Inc. Common Stock positions in Q4 2019 and 3 closed out, a net change of -2 holders.
  • The largest Nemaura Medical, Inc. Common Stock buyer in Q4 2019 was Deutsche Bank, an estimated $1.84K added.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q4 2019 was Citadel Advisors, an estimated $36K sold.

Based on aggregated 13F filings for Q4 2019.